manilatimes23m
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
see the risks and uncertainties detailed in the Company's periodic filings with the Securities and Exchange Commission, ...
Taiwan News18m
Aptose Reports Results for the Third Quarter 2024
Stock-based compensation decreased by approximately $340 thousand in the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to stock options ...
Shares in Trump's social media company spike after president-elect says he won't sell stake
Shares in Donald Trump's social media company spiked after the president-elect again vowed not to sell his stake in the ...